Your browser doesn't support javascript.
loading
¿Se acepta una diferencia de ±20 % en los estudios de bioequivalencia?. Réplica / Is a ±20 % difference in bioequivalence studies accepted?. Reply
Albaladejo, C.
Affiliation
  • Albaladejo, C; CAP Lleflá. Barcelona. España
Hipertensión (Madr., Ed. impr.) ; 24(5): 222-222, sept. 2007.
Article in Es | IBECS | ID: ibc-62516
Responsible library: ES15.1
Localization: ES15.1 - BNCS
ABSTRACT
No disponible
Subject(s)
Search on Google
Add to My VHL
Print
XML
Collection: National databases / Spain Database: IBECS Main subject: Biological Availability / Therapeutic Equivalency Limits: Humans Language: Spanish Journal: Hipertensión (Madr., Ed. impr.) Year: 2007 Document type: Article Institution/Affiliation country: CAP Lleflá/España
Search on Google
Add to My VHL
Print
XML
Collection: National databases / Spain Database: IBECS Main subject: Biological Availability / Therapeutic Equivalency Limits: Humans Language: Spanish Journal: Hipertensión (Madr., Ed. impr.) Year: 2007 Document type: Article Institution/Affiliation country: CAP Lleflá/España